Anti-estrogen plus progestin containing oral contraceptives
US6326392A · kind A · utility
29Cited by
9References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 1998 |
| Grant date | Dec 4, 2001 |
| Priority date | — |
| Expiry date | Nov 3, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method of providing contraception which comprises administering to a female of child bearing age a combination of a non-uterotrophic anti-estrogen and a progestin for 28 days per 28-day menstrual cycle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.